100% of the 41 studies to date report positive effects. Random effects meta-analysis for early treatment and pooled effects shows a reduction of 83%, RR 0.17 [0.11-0.28]. Prophylactic use shows a reduction of 89%, RR 0.11 [0.05-0.23]. Mortality results show 78% lower mortality, RR 0.22 [0.12-0.41] for all treatment delays, and 86% lower, RR 0.14 [0.03-0.62] for early treatment.
Source | https://ivmmeta.com/
